Fractyl Health, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GUTS and other ETFs, options, and stocks.

About GUTS

Fractyl Health, Inc. is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The listed name for GUTS is Fractyl Health, Inc. 

CEO
Harith Rajagopalan
CEOHarith Rajagopalan
Employees
107
Employees107
Headquarters
Burlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded
2010
Founded2010
Employees
107
Employees107

GUTS Key Statistics

Market cap
313.83M
Market cap313.83M
Price-Earnings ratio
-1.01
Price-Earnings ratio-1.01
Dividend yield
Dividend yield
Average volume
5.06M
Average volume5.06M
High today
$2.33
High today$2.33
Low today
$2.10
Low today$2.10
Open price
$2.22
Open price$2.22
Volume
4.53M
Volume4.53M
52 Week high
$3.03
52 Week high$3.03
52 Week low
$0.825
52 Week low$0.825

Stock Snapshot

As of today, Fractyl Health, Inc.(GUTS) shares are valued at $2.24. The company's market cap stands at 313.83M, with a P/E ratio of -1.01.

During the trading session on 2025-12-10, Fractyl Health, Inc.(GUTS) shares reached a daily high of $2.33 and a low of $2.10. At a current price of $2.24, the stock is +6.9% higher than the low and still -3.9% under the high.

Trading volume for Fractyl Health, Inc.(GUTS) stock has reached 4.53M, versus its average volume of 5.06M.

The stock's 52-week range extends from a low of $0.83 to a high of $3.03.

The stock's 52-week range extends from a low of $0.83 to a high of $3.03.

People also own

Based on the portfolios of people who own GUTS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.